Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.2% |
| 2 | Technology | 14.19% |
| 3 | Financials | 12.33% |
| 4 | Consumer Staples | 10.22% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXAC
1876
DELISTED
Exactech Inc
EXAC
| $3.92M | 0.01% |
131,400
+20,800
| +19% | +$611K |
|
|
PXD
1877
DELISTED
Pioneer Natural Resource Co.
PXD
| $3.91M | 0.01% |
24,500
-381,588
| -94% | -$65.2M |
|
1878
Acme United Corp
ACU
$232M
| $3.9M | 0.01% |
136,300
+17,700
| +15% | +$488K |
|
|
LITS
1879
Lite Strategy Inc
LITS
$30.2M
| $3.9M | 0.01% |
81,541
+3,320
| +4% | +$120K |
|
1880
United Fire Group
UFCS
$1.4B
| $3.89M | 0.01% |
88,200
+32,600
| +59% | +$1.41M |
|
1881
First Business Financial Services
FBIZ
$598M
| $3.88M | 0.01% |
168,100
+4,200
| +3% | +$103K |
|
1882
MaxLinear
MXL
$7.69B
| $3.88M | 0.01% |
139,113
-87,839
| -39% | -$2.56M |
|
1883
CVR Energy
CVI
$3.54B
| $3.85M | ﹤0.01% |
+177,000
| New | +$3.63M |
|
1884
Pixelworks
PXLW
$44.4M
| $3.85M | ﹤0.01% |
69,933
+14,233
| +26% | +$836K |
|
|
CHSP
1885
DELISTED
Chesapeake Lodging Trust
CHSP
| $3.85M | ﹤0.01% |
157,400
-94,600
| -38% | -$2.26M |
|
1886
Alpha Pro Tech
APT
$55.4M
| $3.85M | ﹤0.01% |
1,303,405
-105,686
| -8% | -$302K |
|
|
GCAP
1887
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $3.85M | ﹤0.01% |
617,100
-35,300
| -5% | -$229K |
|
1888
Orrstown Financial Services
ORRF
$852M
| $3.83M | ﹤0.01% |
167,562
-2,481
| -1% | -$53.6K |
|
1889
Vicor
VICR
$10.8B
| $3.83M | ﹤0.01% |
213,800
-17,400
| -8% | -$309K |
|
|
PRCP
1890
DELISTED
Perceptron Inc
PRCP
| $3.83M | ﹤0.01% |
525,600
-3,700
| -0.7% | -$29.3K |
|
1891
Perion Network
PERI
$385M
| $3.82M | ﹤0.01% |
646,467
+39,200
| +6% | +$208K |
|
1892
New Jersey Resources
NJR
$5.64B
| $3.81M | ﹤0.01% |
96,000
-88,100
| -48% | -$3.61M |
|
1893
Global Industrial
GIC
$1.48B
| $3.81M | ﹤0.01% |
202,600
-25,994
| -11% | -$407K |
|
|
TRCO
1894
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $3.79M | ﹤0.01% |
92,900
-602,200
| -87% | -$23.6M |
|
|
APEX
1895
DELISTED
Apex Global Brands Inc. Common Stock
APEX
| $3.77M | ﹤0.01% |
18,082
-165
| -0.9% | -$40.5K |
|
|
WSR
1896
DELISTED
Whitestone REIT
WSR
| $3.77M | ﹤0.01% |
307,701
-24,999
| -8% | -$313K |
|
|
PWOD
1897
DELISTED
Penns Woods Bancorp
PWOD
| $3.74M | ﹤0.01% |
136,200
+18,450
| +16% | +$502K |
|
|
MANT
1898
DELISTED
Mantech International Corp
MANT
| $3.74M | ﹤0.01% |
90,300
+68,867
| +321% | +$2.6M |
|
1899
Park-Ohio Holdings
PKOH
$716M
| $3.73M | ﹤0.01% |
97,800
-11,200
| -10% | -$420K |
|
|
TCF
1900
DELISTED
TCF Financial Corporation
TCF
| $3.72M | ﹤0.01% |
233,600
+10,948
| +5% | +$176K |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.